AstraZeneca Settles Dispute Over Prilosec OTC

Law360, New York (November 1, 2007, 12:00 AM EDT) -- Generic drugmaker Dexcel Pharma Technologies Ltd. has reached a settlement with AstraZeneca in a patent dispute over Prilosec OTC, Dexcel partner Perrigo Co. revealed Thursday.

The new agreement paves the way for over-the-counter pharmaceutical company Perrigo to become the exclusive U.S. distributor of store-brand Prilosec OTC, developed and made by Dexcel.

Under the agreement, Dexcel and Perrigo will be able to sell a store-brand version of the popular heartburn medication as soon as the U.S. Food and Drug Administration issues its final regulatory approval. Perrigo estimates...
To view the full article, register now.